Snapshot

The Recognition pathway has been developed by the of Tanzania.

This pathway can be used where TMDA may use reliance through recognition of the other regulatory decision to expedite the approval of marketing authorisation of the medicinal products. TMDA may be engaged in unilateral and mutual recognition with recognized regulatory authorities and organisations, inter alia AMA, EMA, WHO/ML4 and WLA. The recognition shall be guided by formal agreements between the Parties..

This pathway accelerates the regulatory review process.

It is a verification review (a recognition pathway).

Target time assessment is Info not found..